Dr. Swaminathan Smita Iyer's lab focuses on developing innovative HIV vaccines that enhance the immune response to provide long-lasting protection against the virus. The research specifically investigates CD4 T follicular helper cells, which play a crucial role in stimulating B cells to produce antibodies. By experimenting with different vaccine platforms and adjuvants, the lab aims to improve the durability and effectiveness of HIV antibodies, contributing to the development of more effective vaccines.

Dr. Hong Ji's lab at UC Davis focuses on understanding how air pollution affects lung health, particularly through the study of specific molecular mechanisms in airway cells. The team's research investigates how TET1, a protein involved in modifying DNA, interacts with RNA modifications that impact inflammation caused by particulate matter. Their work aims to uncover the details of these interactions to help find new ways to treat lung diseases triggered by pollution.

Dr. Marshall Horwitz's lab focuses on understanding congenital neutropenia, a condition where the body has dangerously low levels of a type of white blood cell called neutrophils, increasing the risk of infections. They explore genetic mutations that impact neutrophil development and function, using innovative human stem cell models to study how these mutations disrupt normal blood cell formation. The goal is to uncover the mechanisms behind this and potentially find new ways to treat these disorders.

Dr. Shaoping Hou's lab at the University of Missouri-Columbia focuses on understanding how specific dopamine receptors in the spinal cord affect bladder control after spinal cord injuries. They investigate how these receptors can change in response to injury and how stimulating them might help restore urinary function. By using various experimental techniques, the lab aims to develop potential new treatments for urinary disorders that arise from spinal cord injuries.

Dr. Mayumi Nakagawa's lab focuses on developing innovative therapeutic vaccines to enhance immune responses against high-risk human papillomaviruses (HPV), which are responsible for several cancers including cervical and head and neck cancers. The lab is actively conducting clinical trials to evaluate the safety and effectiveness of PepCan, a vaccine designed to boost T-cell responses in patients with HPV-related lesions and cancers. Their research aims to provide alternative treatments that are safer for women who want to preserve their fertility while effectively targeting HPV-related diseases.

Dr. Eric J. Huang's lab at Washington University studies the mechanisms of neurodegeneration associated with mutations in the GRN gene, which is linked to diseases like frontotemporal lobar degeneration and Alzheimer’s disease. The lab focuses on how defects in lipid metabolism and endolysosomal trafficking in brain cells contribute to neuronal vulnerability. Through both human and mouse models, they aim to identify therapeutic targets for age-related neurodegenerative diseases.

Dr. Jiaoti Huang's lab at Duke University focuses on understanding the complex mechanisms behind prostate cancer progression, particularly two aspects: the role of alternative polyadenylation in cancer development and the targeting of hard-to-reach transcription factors to hinder metastasis. The lab aims to uncover how specific genetic and molecular changes fuel prostate cancer's progression to more aggressive forms and develop innovative therapeutic strategies to improve patient outcomes.

Cheng Huang's research lab at the University of Texas Medical Branch in Galveston focuses on understanding the biology of the Lassa virus, which causes Lassa fever, a significant health threat in West Africa. The lab is investigating a specific protein called the nucleoprotein (NP) that helps the virus evade the immune system and maintains the virus's genetic integrity. By studying how NP reduces errors during RNA replication, the lab aims to develop better treatments and vaccines against Lassa fever.

Dr. Krystalyn Hudson's research focuses on understanding autoimmune hemolytic anemia (AIHA), a condition where the immune system mistakenly targets and destroys red blood cells. The lab investigates how the immune system achieves tolerance to red blood cell antigens and what goes wrong in AIHA. They use innovative mouse models to explore the interplay between different T cell populations and signaling molecules involved in immune responses, aiming to develop better strategies for prevention and treatment.

Dr. Terence D Capellini's lab at Harvard University focuses on studying the genes that determine the unique features of the human skeleton compared to other mammals, particularly mice. By examining the human fetal skeleton, the lab uses advanced genomic techniques to find causal genetic variants linked to skeletal diseases. Their work aims to enhance our understanding of musculoskeletal development, which can lead to better insights into conditions like hip dysplasia and osteoarthritis.

Dr. Kathleen T. Montone's lab at the University of Pennsylvania focuses on collecting high-quality human tissue samples to support biomedical research in various diseases, particularly cancer and autoimmunity. The lab operates as part of the Cooperative Human Tissue Network, providing essential resources for researchers. By facilitating access to well-characterized biospecimens, the lab aims to foster innovation in diagnostics and therapeutics that can ultimately enhance public health.

Dr. Christopher Hunter's lab focuses on understanding immune responses to intestinal infections, particularly from the parasite Cryptosporidium, which poses serious health risks to children and individuals with immune deficiencies. The team explores the roles of immune molecules and pathways, such as CD40L and IL-22, in developing protective immunity, with the goal of guiding vaccine development and improving infection management. Through innovative techniques like parasite genetics and mouse models, they aim to harness the immune system to improve health against gastrointestinal diseases.

Dr. Eric Hunter's lab focuses on understanding the immune system's response to HIV infections, particularly how these responses differ between men and women. They seek to uncover mechanisms that could lead to better vaccines and treatments. The lab conducts research involving both human cohorts and nonhuman primate models to explore effective responses to HIV and factors that affect viral loads and immune activation.

Dr. David R. Hyde's lab at the University of Notre Dame focuses on understanding why zebrafish can regenerate retinal neurons after acute damage, but not after chronic damage. This research is crucial for developing therapies to treat human vision loss caused by gradual retinal degeneration. Through innovative techniques, the lab explores the roles of retinal cells and immune responses in the regeneration process, aiming to leverage these insights for clinical applications.

Dr. Kei M. Igarashi's lab at UC Irvine specializes in understanding the brain circuits involved in memory formation and retrieval, particularly in the context of Alzheimer's disease. The lab conducts research on the lateral entorhinal cortex, which plays a crucial role in these cognitive functions. By using advanced techniques such as optogenetics and transgenic mouse models, the lab aims to identify the specific neuronal types impacted by Alzheimer's to develop potential treatments for memory impairments.

Dr. Matthew Krummel's lab at UCSF focuses on understanding how the immune system distinguishes between self and foreign cells. Through innovative research on immune cells like T cells and dendritic cells, the lab aims to improve treatments for cancer and autoimmune diseases. They explore specific cellular mechanisms that could enhance the effectiveness of immunotherapies, ultimately aiming to boost the body's ability to fight tumors while minimizing autoimmunity.

Dr. Ari B. Molofsky's lab at UCSF focuses on understanding the immune system's responses to allergens and brain injuries. The research primarily investigates how certain immune cells, called type 2 lymphocytes, function and localize within tissues during inflammation. The lab also explores the role of fibroblast cells in the brain and how they interact with the immune system to influence recovery from injury. The findings aim to inform future therapies for allergic diseases and neuroinflammatory conditions.

Dr. Gisela Gabernet's lab at Yale University focuses on developing advanced computational tools for analyzing immune system data, particularly related to B cell and T cell responses. The lab works on processing high-throughput sequencing data to better understand immune reactions to infections and diseases, creating user-friendly software tools to help other researchers. By making data analysis easier and more accessible, the lab aims to enhance research in infectious diseases and immune-mediated conditions.

Dr. Koushik Roy's lab focuses on understanding how certain proteins control the development of immune cells that produce antibodies, specifically targeting the processes that help create long-lasting immunity. In particular, the lab studies how different signaling pathways affect the formation of memory B cells and plasma cells, which are critical for responding to infections and vaccines. The research aims to uncover mechanisms that could lead to improved vaccines and therapies for better immune responses.

Dr. Sarah Caddy's lab at Cornell University focuses on understanding how maternal antibodies affect the efficacy of oral vaccines in infants. This research is particularly important for improving rotavirus vaccination strategies, especially in low-income countries where rotavirus causes severe gastroenteritis in children. Through studying both human samples and developing mouse models, the lab aims to uncover the mechanisms behind maternal antibody interference and identify ways to enhance vaccine responses in infants.